Therapeutic Asset Ratings
4,337 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Calcium folinate pentahydrate
Serum Ferritin
Tianjin Medical University Cancer Institute and Hospital
N/A
D
(30)
Calcium folinate pentahydrate
Small Intestinal Carcinoma
Alliance for Clinical Trials in Oncology
N/A
D
(30)
Calcium folinate pentahydrate
Transarterial Chemoembolization
Third Affiliated Hospital, Sun Yat-Sen University
N/A
D
(30)
Calcium folinate pentahydrate
Ultrasound Therapy
Seoul National University Hospital
N/A
D
(30)
Calcium hydroxide
Apical Periodontitis
Ege University
N/A
D
(30)
Calcium hydroxide
Intracanal Medicament
Ege University
N/A
D
(30)
Calcium hydroxide
Post Operative Pain
Ege University
N/A
D
(30)
Calcium hydroxide
Root Canal Treatment
Ege University
N/A
D
(30)
Calculus Bovis Sativus
Neuromyelitis Optica
Tongji Hospital
N/A
D
(30)
Calendula
Breast Carcinoma
OHSU Knight Cancer Institute
N/A
D
(30)
Calendula
Head And Neck Carcinoma
OHSU Knight Cancer Institute
N/A
D
(30)
Calendula
Radiodermatitis
OHSU Knight Cancer Institute
N/A
D
(30)
Canagliflozin
HIV Infectious Disease
xiaolong zhao
N/A
D
(30)
Canagliflozin
Prediabetes Syndrome
xiaolong zhao
N/A
D
(30)
Cannabis Sativa L., Folium Cum Flore
Neuralgia
Albina Nowak, MD
N/A
D
(30)
Capecitabine
Acute Leukemia
Tianjin Medical University Cancer Institute and Hospital
N/A
D
(30)
Capecitabine
Bone Resorption
University of Georgia
N/A
D
(30)
Capecitabine
Browning of Subcutaneous White Adipose Tissue Post Intervention
University of Sao Paulo
N/A
D
(30)
Capecitabine
Calcium
University of Georgia
N/A
D
(30)
Capecitabine
Cognitive Decline
Pusan National University Yangsan Hospital
N/A
D
(30)
Capecitabine
Consolidation Therapy
Seoul National University Hospital
N/A
D
(30)
Capecitabine
Electroacupuncture
Affiliated Hospital of Qinghai University
N/A
D
(30)
Capecitabine
Gastrointestinal
ClostraBio Inc.
N/A
D
(30)
Capecitabine
HER-2 Positive Breast Cancer
University of Vermont Medical Center
N/A
D
(30)
Capecitabine
Immune-related Adverse Event
Tianjin Medical University Cancer Institute and Hospital
N/A
D
(30)
Showing 651 to 675 of 4,337 assets
Previous
Page 27 of 174
Next